A detailed history of Full Sail Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Full Sail Capital, LLC holds 4,524 shares of AZN stock, worth $348,302. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,524
Previous 7,073 36.04%
Holding current value
$348,302
Previous $476,000 35.71%
% of portfolio
0.02%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$61.03 - $69.57 $155,565 - $177,333
-2,549 Reduced 36.04%
4,524 $306,000
Q4 2023

Feb 13, 2024

SELL
$61.89 - $69.28 $115,734 - $129,553
-1,870 Reduced 20.91%
7,073 $476,000
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $2,010 - $2,222
31 Added 0.35%
8,943 $605,000
Q1 2023

May 04, 2023

BUY
$63.15 - $71.6 $3,599 - $4,081
57 Added 0.64%
8,912 $618,000
Q4 2022

Feb 06, 2023

SELL
$54.21 - $70.44 $17,184 - $22,329
-317 Reduced 3.46%
8,855 $600,000
Q3 2022

Nov 09, 2022

SELL
$53.02 - $135.75 $13,891 - $35,566
-262 Reduced 2.78%
9,172 $503,000
Q1 2022

May 12, 2022

SELL
$55.72 - $67.12 $3,454 - $4,161
-62 Reduced 0.65%
9,434 $626,000
Q2 2021

Aug 12, 2021

SELL
$48.42 - $60.18 $165,838 - $206,116
-3,425 Reduced 26.51%
9,496 $569,000
Q4 2020

Feb 11, 2021

BUY
$48.52 - $58.02 $18,389 - $21,989
379 Added 3.02%
12,921 $704,000
Q3 2020

Nov 13, 2020

SELL
$53.07 - $61.1 $20,113 - $23,156
-379 Reduced 2.93%
12,542 $692,000
Q1 2020

May 15, 2020

SELL
$37.79 - $51.33 $6,726 - $9,136
-178 Reduced 1.36%
12,921 $688,000
Q4 2019

Feb 14, 2020

SELL
$42.46 - $50.46 $1,953 - $2,321
-46 Reduced 0.35%
13,099 $650,000
Q3 2019

Nov 20, 2019

SELL
$40.12 - $45.47 $641 - $727
-16 Reduced 0.12%
13,145 $629,000
Q2 2019

Aug 14, 2019

SELL
$37.28 - $41.68 $1,118 - $1,250
-30 Reduced 0.23%
13,161 $589,000
Q1 2019

May 16, 2019

BUY
$35.49 - $43.02 $468,148 - $567,476
13,191 New
13,191 $533,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $239B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Full Sail Capital, LLC Portfolio

Follow Full Sail Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Full Sail Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Full Sail Capital, LLC with notifications on news.